Cargando…
P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY
Autores principales: | Chang, Long, Lang, Min, Duan, Minghui, LI, Jian, Zhou, Dao-Bin, Cao, Xin-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431420/ http://dx.doi.org/10.1097/01.HS9.0000971052.20461.da |
Ejemplares similares
-
Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis
por: Liu, Ting, et al.
Publicado: (2022) -
P544: SINGLE-SYSTEM UNIFOCAL ADULT LANGERHANS CELL HISTIOCYTOSIS: A SINGLE-CENTER RETROSPECTIVE STUDY
por: Lang, Min, et al.
Publicado: (2023) -
PB2197: ADULT LANGERHANS CELL HISTIOCYTOSIS WITH LIVER INVOLVEMENT
por: Chang, Long, et al.
Publicado: (2023) -
Langerhans cell histiocytosis in adolescent patients: a single-centre retrospective study
por: Cai, Hua-cong, et al.
Publicado: (2022) -
Cladribine and cytarabine in children refractory high risk multisystem Langerhans cell histiocytosis
por: Wang, Wenqian, et al.
Publicado: (2023)